From 'cold' to 'hot' in just 48 hours. Novel mRNA vaccine technology rapidly reprograms the tumor microenvironment, triggering a robust immune response against cancer. hubs.ly/Q02vVDQL0

Scientists at UF Health have developed multi-lamellar RNA-LPAs to enhance cancer vaccine delivery. Find out further details here >>> hubs.ly/Q02vVfjL0

OPTYX study aims to generate evidence on ORGOVYX's safety and effectiveness in prostate cancer patients in routine care, including treatment course and post-treatment clinical outcomes. >>> hubs.ly/Q02tC7bd0

Our partnered journal Future Oncologu recently published a Clinical Trial Protocol of the OPTYX study, which aims to generate evidence on ORGOVYX’s® (relugolix) safety and effectiveness in prostate cancer patients. hubs.ly/Q02tC4KX0

How did a decade of research inform the latest @ACSO guidelines? Find out on Oncology Central >>> hubs.ly/Q02rFTZf0

Our partnered journal Future Oncologu recently published a Clinical Trial Protocol of the OPTYX study, which aims to generate evidence on ORGOVYX’s® (relugolix) safety and effectiveness in prostate cancer patients. hubs.ly/Q02tC8m-0

What challenges are associated with value-based oncology care and how can these be overcome? Read out latest interview feature to find out >>> bit.ly/4cK78di

Discover the strides being made to unravel the complexities of brain tumors in our interview with Karen Noble from Brain Tumour Research
hubs.ly/Q02ntP6g0
#IWD24

How could #AI and value-based care can influence healthcare delivery help create better care journeys? Find out in our latest interview >>> bit.ly/4ajBRMU

Attending #AACR24 in San Diego? Have a read of our news roundup to keep up-to-date with all the breaking stories from the conference! hubs.ly/Q02sh3tN0

Vaccination, revaccination, and coordination: What can we learn from ASCO’s latest set of healthcare guidelines? Find out on Oncology Central. hubs.ly/Q02rFSsR0

Explore opportunities for women in neuro-oncology, with insights from Sylvester Comprehensive Cancer Center's Macarena de la Fuente, who has been the co-chair of the Society for Neuro-Oncology’s Women and Diversity Committee: hubs.ly/Q02m_VCd0 SNO

.ASCO has released their latest recommendations on vaccinating cancer patients. Read all about how these guidelines could influence clinical decision making here >>> hubs.ly/Q02rFVxK0

Radka Stoyanova Sylvester Comprehensive Cancer Center is using AI to both detect glioblastoma tumor volume changes and build models to predict the response of a patient to a particular treatment. hubs.ly/Q02nkq1V0

From data infrastructure to patient empowerment, learn about the multifaceted approach to overcoming hurdles in value-based oncology care >>> bit.ly/4cSOdgK

Learn more about the eNRGy Phase I/II trial, a study investigating zenocutuzumab administered to patients with cancer caused by NRG1 gene fusions >>> bit.ly/4325eAE

eNRGy is a global Phase I/II trial currently recruiting patients with NRG1+ NSCLC, PDAC, or other solid tumors to assess zenocutuzumab, an investigational bispecific IgG1 antibody that inhibits NRG1-activated
HER2/HER3 oncogenic signaling bit.ly/3wLYBGc

What are the latest developments in diagnostic and therapeutic options for #PancreaticCancer patients? Find out in our interview with Mandana Kamgar (Medical College of Wisconsin) hubs.ly/Q02m-hYr0
#IWD2024 #InspireInclusion

Learn more about the eNRGy Phase I/II trial, a study investigating zenocutuzumab administered to patients with cancer caused by NRG1 gene fusions >>> bit.ly/3SWeH7P
@Future_OncolFSG

New research suggests a potential alternative to traditional FIT tests for colorectal cancer screening. With superior sensitivity, this next-generation stool DNA test offers improved detection. hubs.ly/Q02pRgCX0